AFP and fatty liver disease: predictors of response (3.65, 0.1); stereotactic body radiotherapy (3.65, 0.1); alpha fetoprotein (3.65, 0.1); fatty liver disease (3.65, 0.1); randomized controlled trial (3.65, 0.1)